1052
Vol. 55, No. 7
was concentrated in vacuo. The residue was chromatographed on silica
gel (solvent CHCl3–MeOH, 8 : 2) to give 4 (10.5 mg, 90%). [a]D ꢁ17.1°
1
(cꢂ1.0, H2O). Positive-ion FAB-MS m/z: 336 [MꢃH]ꢃ. H-NMR (D2O) d:
4.44 (1H, m, 4-H), 4.34 (1H, m, 7-H), 4.14 (1H, m, 8-H), 4.12 (1H, m, 9-H),
3.90 (3H, s, COOCH3), 3.77 (1H, m, 9-H), 3.56 (1H, m, 6-H), 3.30 (3H, s,
OCH3), 2.80 (1H, m, 5-H), 2.47 (1H, dd, Jꢂ12.9, 11.5 Hz, 3-H), 1.85 (1H,
dd, Jꢂ12.9, 5.1 Hz, 3-H), 1.45, 1.40 [each 3H, s, C(CH3)2].
Preparation of D-Arabinose (6) from 4 To the solution of 4 (10.5 mg)
in H2O (0.5 ml), NaIO4 (1.0 mg) was added and stirred at room temperature
for 1 h. The reaction mixture was diluted with H2O (5 ml) and a small
amount of ethylene glycol, and extracted with n-BuOH (3 mlꢀ3). The
organic layer was washed with H2O and concentrated in vacuo to give 5
as a crude product. Compound 5 was heated with 90% HCOOH–10%
CF3COOH (1 : 1) (0.5 ml) at 100 °C for 12 h, and the reaction mixture was
concentrated in vacuo. The residue was purified on silica gel TLC (solvent
CHCl3–MeOH–H2O, 7 : 3 : 0.5) to give 6 (2.3 mg, 50% from 4).
Preparation of L-Arabinose (8) from L-NeuAc (7) In the same manner
as for 1, compound 7 (8.4 mg) afforded 8 (1.8 mg, 44.1%).
Determination of the Absolute Configuration of 6 and 8 (Hara
Method) Compounds 6 (1 mg) and 8 (1 mg) were each heated with L-cys-
teine methyl ester hydrochloride (1.5 mg) and pyridine (0.2 ml) at 70 °C for
1 h. Then, 0.1 ml of 1-(trimethylsilyl) imidazole was added and the mixture
was heated at 70 °C for a further 15 min. The reaction mixture was diluted
with 50% MeOH (0.8 ml), extracted with n-hexane (0.5 mlꢀ3), and the n-
hexane layer was concentrated in vacuo to yield trimethylsilyl ether of the
methyl (4R)-thiazolidine-4-carboxylate derivative. Each derivative was ana-
lyzed using gas chromatography [column temperature: 180—300 °C (rate of
temperature increase 2.5 °C/min)]; tR [min]ꢂ23.5 (derivative of 6), 22.1 (de-
rivative of 8) (derivative of D-arabinose, 23.5, L-arabinose, 22.1).
Determination of the Absolute Configuration of Sialic Acid Residues
of Gangliosides from C. echinata Each ganglioside (2 mg) shown in Fig.
2 was heated with 10% HCl in MeOH (0.5 ml) at 80 °C for 18 h and concen-
trated in vacuo. The residue was dissolved in DMF (0.3 ml), and acetone
(0.3 ml) and 10% HCl in MeOH (10 ml) were added. The mixture was heated
at 60 °C for 4 h, neutralized with Ag2CO3, centrifuged, and the clear super-
natant solution was concentrated in vacuo. To the solution of the product in
H2O (0.5 ml), NaIO4 (1.0 mg) was added and stirred at room temperature for
1 h. The reaction mixture was diluted with H2O (5 ml) and a small amount of
ethylene glycol, and extracted with n-BuOH (3 mlꢀ3). The organic layer
was concentrated in vacuo, the reaction product was heated with 90%
HCOOH–10% CF3COOH (1 : 1) (0.5 ml) at 100 °C for 12 h, and the reaction
mixture was concentrated in vacuo. The arabinose from sialic acid, con-
tained in the reaction product, was induced to the thiazolidine derivative, and
the derivative was analyzed using gas chromatography in the same manner
as in 6; tR [min] (original ganglioside)ꢂ23.5 (SJG-1), 23.5 (CG-1), 23.5
(CEG-3), 23.4 (CEG-4), 23.4 (CEG-5), 23.5 (CEG-6), 23.5 (HLG-3), 23.5
(CEG-8), 23.4 (CEG-9) (derivative of D-arabinose, 23.5, L-arabinose, 22.1).
Fig. 2. Determination of the Absolute Configuration of Sialic Acid
Residues of Gangliosides from Cucumaria echinata by Conversion to Arabi-
nose
SJG-1: NeuGca2→6Glcb1→1 ceramide
CG-1: 8-O-sulfo-NeuGca2→6Glcb1→1 ceramide
CEG-3: 4-O-acetyl-Fuca1→11NeuGca2→6Glcb1→1 ceramide
CEG-4: Fuca1→11NeuGca2→6Glcb1→1 ceramide
CEG-5: Fuca1→11NeuGca2→6Glcb1→1 ceramide
CEG-6: Fuca1→11NeuGca2→4NeuAca2→6Glcb1→1 ceramide
HLG-3: Fuca1→11NeuGca2→4NeuAca2→6Glcb1→1 ceramide
CEG-8: NeuGc2→11NeuGc2→4NeuAc2→6Glc1→1 ceramide
CEG-9: NeuGc2→11NeuGc2→4NeuAc2→6Glc1→1 ceramide
Bold: sialic acid
residues in gangliosides using chemical methods and thus is
noteworthy.
Experimental
Optical rotations were measured with a Jasco Dip-370 digital polarimeter
1
at 23 °C. H-NMR spectra were recorded on a Jeol GX-270 spectrometer
(270 MHz) or a Varian Unity-500 spectrometer (500 MHz). Positive- and
negative-ion FAB-MS spectra were acquired with a Jeol JMS-SX-102 mass
spectrometer [xenon atom beam; matrix, m-nitrobenzylalcohol (positive-ion
mode) and triethanolamine (negative-ion mode)]. Gas chromatographs were
recorded with a Shimadzu QP-5050A [EI mode; ionizing potential, 120 eV;
column, Neutra Bond-5 (0.25 mmꢀ30 m, GL Science Inc.); carrier gas, He].
N-Acetyl-2,4,7,8,9-penta-O-acetyl-D-neuraminic Acid (2) D-NeuAc
(1) (20 mg) was heated with Ac2O (0.5 ml) and pyridine (0.5 ml) at 60 °C for
2 h. The reaction mixture was concentrated in vacuo to give 2 (33.4 mg).
Acknowledgments We thank Mr. Y. Tanaka and Ms. Y. Soeda of the
Faculty of Pharmaceutical Sciences, Kyushu University, for the NMR meas-
urements. This work was supported in part by a Grant-in-Aid for Scientific
Research (No. 13024260, Priority Area A) from the Ministry of Education,
Culture, Science, Sports and Technology, Japan, and a grant (No. 16510163,
18510187) from the Japan Society for the Promotion of Science, which are
gratefully acknowledged.
1
[a]D ꢁ10.4° (cꢂ1.0, H2O). Negative-ion FAB-MS m/z: 518 [MꢁH]ꢁ. H-
NMR (D2O) d: 5.43 (1H, dd, Jꢂ7.7, 1.8 Hz, 7-H), 5.29 (1H, ddd, Jꢂ11.5,
10.3, 5.1 Hz, 4-H), 5.17 (1H, ddd, Jꢂ7.7, 4.1, 3.0 Hz, 8-H), 4.45 (2H, dd,
Jꢂ12.8, 3.0 Hz, 9-H2), 4.10 (1H, dd, Jꢂ10.6, 1.8 Hz, 6-H), 3.94 (1H, t,
Jꢂ10.4 Hz, 5-H), 2.45 (1H, dd, Jꢂ13.6, 11.5 Hz, 3-H), 1.87 (1H, dd,
Jꢂ13.6, 5.1 Hz, 3-H), 1.99, 2.02, 2.03, 2.03, 2.12, 2.14 (each 3H, s,
COCH3ꢀ6).
References and Notes
1) Hakomori S., Igarashi Y., J. Biochem. (Tokyo), 118, 1091—1103
(1995).
2) Comb D. G., Roseman S., J. Biol. Chem., 235, 2529—2537 (1960).
3) Kisa F., Yamada K., Miyamoto T., Inagaki M., Higuchi R., Chem.
Pharm. Bull., 54, 982—987 (2006).
4) Kisa F., Yamada K., Miyamoto T., Inagaki M., Higuchi R., Chem.
Pharm. Bull., 54, 1293—1298 (2006).
5) The Hara method is a well-known method using determination of the
absolute configuration of aldoses in which trimethylsilyl ethers of the
methyl (4R)-thiazolidine-4-carboxylate derivative of aldose enan-
tiomers can be separated by GLC; Hara S., Okabe H., Mihashi K.,
Chem. Pharm. Bull., 35, 501—506 (1987).
Methyl 2-O-Methyl-D-neuraminate (3) Compound 2 (33.4 mg) was
heated with 10% HCl in MeOH (0.5 ml) at 80 °C for 18 h. The reaction mix-
ture was concentrated in vacuo and the residue was chromatographed on sil-
ica gel (solvent CHCl3–MeOH–H2O, 6 : 4 : 1) to give 3 (10.3 mg, 54% from
1). [a]D ꢁ23.2° (cꢂ1.0, H2O). Positive-ion FAB-MS m/z: 296 [MꢃH]ꢃ. 1H-
NMR (D2O) d: 4.42 (1H, m, 4-H), 4.19 (1H, m, 7-H), 4.05 (1H, m, 8-H),
3.95 (2H, m, 9-H2), 3.92 (3H, s, COOCH3), 3.53 (1H, m, 6-H), 3.30 (3H, s,
OCH3), 2.84 (1H, m, 5-H), 2.68 (1H, dd, Jꢂ13.2, 12.0 Hz, 3-H), 1.78 (1H,
dd, Jꢂ13.2, 4.5 Hz, 3-H).
Methyl 8,9-O-Isopropylidene-2-O-methyl-D-neuraminate (4) Com-
pound 3 (10.3 mg) was dissolved in DMF (0.5 ml), and acetone (0.5 ml) and
10% HCl in MeOH (20 ml) were added. The mixture was heated at 60 °C for
4 h, neutralized with Ag2CO3, centrifuged, and the clear supernatant solution
6) Kozlov I. A., Mao S., Xu Y., Huang X., Lee L., Sears P. S., Gao C.,
Coyle A. R., Janda K. D., Wong C.-H., ChemBioChem, 2, 741—746
(2001).